ID

43633

Beschreibung

Lapatinib Resistance in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00898573

Link

https://clinicaltrials.gov/show/NCT00898573

Stichworte

Versionen (2)
  1. 25.10.17 25.10.17 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00898573

Englisch

Eligibility Breast Cancer NCT00898573

1 Formulare  
Criteria
Beschreibung

Criteria

pathologically confirmed invasive breast cancer
Beschreibung

Invasive carcinoma of breast

Datentyp

boolean

Alias
UMLS CUI [1]
C0853879
erbb2-positive disease
Beschreibung

Disease HER2/Neu Positive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348909
has received or is currently receiving lapatinib ditosylate
Beschreibung

lapatinib ditosylate

Datentyp

boolean

Alias
UMLS CUI [1]
C1504917
documented clinical benefit while receiving lapatinib ditosylate (e.g., stable disease of ≥ 12 weeks duration or a radiographic response)
Beschreibung

lapatinib ditosylate | Benefit Clinical | Stable Disease | Response Radiography

Datentyp

boolean

Alias
UMLS CUI [1]
C1504917
UMLS CUI [2,1]
C0814225
UMLS CUI [2,2]
C0205210
UMLS CUI [3]
C0677946
UMLS CUI [4,1]
C1704632
UMLS CUI [4,2]
C0034571
must have tumor tissue samples available for research studies
Beschreibung

Tumor tissue sample Available Research study

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C0681814
hormone receptor status not specified
Beschreibung

Hormone Receptor Status Unspecified

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
menopausal status not specified
Beschreibung

Menopausal Status Unspecified

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3829127
UMLS CUI [1,2]
C0205370
not pregnant*
Beschreibung

Pregnancy Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
coagulation profile normal*
Beschreibung

Coagulation profile Normal

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005790
UMLS CUI [1,2]
C0205307
platelet count > 100,000/mm³* note: *for patients requiring a post-treatment biopsy
Beschreibung

Platelet Count measurement | Biopsy post treatment Patient need for

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2,1]
C0005558
UMLS CUI [2,2]
C2709088
UMLS CUI [2,3]
C0686904
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschreibung

ID.13

Datentyp

boolean

concurrent chemotherapy or trastuzumab (herceptin®) allowed
Beschreibung

Chemotherapy | trastuzumab | Herceptin

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0728747
UMLS CUI [3]
C0338204
no concurrent anticoagulants, including warfarin or low-molecular weight heparin*
Beschreibung

Exclusion Criteria | Anticoagulants | Warfarin | Heparin, Low-Molecular-Weight

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0003280
UMLS CUI [3]
C0043031
UMLS CUI [4]
C0019139
no concurrent antiplatelet therapy, including aspirin, clopidogrel, or other antiplatelet agents* note: *for patients requiring a post-treatment biopsy
Beschreibung

Exclusion Criteria | Antiplatelet therapy | Aspirin | clopidogrel | Antiplatelet Agents | Biopsy post treatment Patient need for

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C1096021
UMLS CUI [3]
C0004057
UMLS CUI [4]
C0070166
UMLS CUI [5]
C0085826
UMLS CUI [6,1]
C0005558
UMLS CUI [6,2]
C2709088
UMLS CUI [6,3]
C0686904
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00898573

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Invasive carcinoma of breast
Item
pathologically confirmed invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Disease HER2/Neu Positive
Item
erbb2-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
lapatinib ditosylate
Item
has received or is currently receiving lapatinib ditosylate
boolean
C1504917 (UMLS CUI [1])
lapatinib ditosylate | Benefit Clinical | Stable Disease | Response Radiography
Item
documented clinical benefit while receiving lapatinib ditosylate (e.g., stable disease of ≥ 12 weeks duration or a radiographic response)
boolean
C1504917 (UMLS CUI [1])
C0814225 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
C0677946 (UMLS CUI [3])
C1704632 (UMLS CUI [4,1])
C0034571 (UMLS CUI [4,2])
Tumor tissue sample Available Research study
Item
must have tumor tissue samples available for research studies
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0681814 (UMLS CUI [1,3])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C3829127 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
Pregnancy Absent
Item
not pregnant*
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Coagulation profile Normal
Item
coagulation profile normal*
boolean
C0005790 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
Platelet Count measurement | Biopsy post treatment Patient need for
Item
platelet count > 100,000/mm³* note: *for patients requiring a post-treatment biopsy
boolean
C0032181 (UMLS CUI [1])
C0005558 (UMLS CUI [2,1])
C2709088 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.13
Item
see disease characteristics
boolean
Chemotherapy | trastuzumab | Herceptin
Item
concurrent chemotherapy or trastuzumab (herceptin®) allowed
boolean
C0392920 (UMLS CUI [1])
C0728747 (UMLS CUI [2])
C0338204 (UMLS CUI [3])
Exclusion Criteria | Anticoagulants | Warfarin | Heparin, Low-Molecular-Weight
Item
no concurrent anticoagulants, including warfarin or low-molecular weight heparin*
boolean
C0680251 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
C0043031 (UMLS CUI [3])
C0019139 (UMLS CUI [4])
Exclusion Criteria | Antiplatelet therapy | Aspirin | clopidogrel | Antiplatelet Agents | Biopsy post treatment Patient need for
Item
no concurrent antiplatelet therapy, including aspirin, clopidogrel, or other antiplatelet agents* note: *for patients requiring a post-treatment biopsy
boolean
C0680251 (UMLS CUI [1])
C1096021 (UMLS CUI [2])
C0004057 (UMLS CUI [3])
C0070166 (UMLS CUI [4])
C0085826 (UMLS CUI [5])
C0005558 (UMLS CUI [6,1])
C2709088 (UMLS CUI [6,2])
C0686904 (UMLS CUI [6,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video